Monaghan Medical Corporation Receives Innovative Technology Designation from Vizient for the AEROBIKA® OPEP device
Designation recognizes products that bring improvements to the health care industry.
Designation recognizes products that bring improvements to the health care industry.
- TAGS
- staronepr
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Obstructive Pulmonary Disease. COPD. 2016;13(1):66-74.<br />
2. Burudpakdee C, Seetasith A, Dunne P, et al. A real-world study of 30-day exacerbation outcomes in<br />
chronic obstructive pulmonary disease (COPD) patient managed with Aerobika <strong>OPEP</strong>. Pulmonary<br />
Therapeutics. 2017.<br />
For clinical inquiries, please contact:<br />
Dominic P. Coppolo, MBA, RRT, FAARC<br />
Vice President Clinical Strategy and Development<br />
<strong>Monaghan</strong> <strong>Medical</strong> <strong>Corporation</strong><br />
1-800-343-9071
Change language